Form 4 Filing for Annovis Bio, Inc.

2026-04-03SEC Filing 4 (0001104659-26-039675)

Michael B. Hoffman, a director at Annovis Bio, Inc., reported a transaction on April 2, 2026. He acquired 713,800 shares of Common Stock at a price of $2.10 per share. Following this transaction, Hoffman directly owns 3,288,539 shares. Additionally, he has indirect ownership of 223,357 shares held within The 2024 Hoffman Family Trust, over which he maintains voting and investment power. The filing, designated as Form 4, was signed by Maria Maccecchini as Attorney-in-Fact on April 3, 2026. This transaction is related to the ownership of securities by a company insider.